Unknown

Dataset Information

0

Elucidating Fibroblast Growth Factor-Induced Kinome Dynamics Using Targeted Mass Spectrometry and Dynamic Modeling.


ABSTRACT: Fibroblast growth factors (FGFs) are paracrine or endocrine signaling proteins that, activated by their ligands, elicit a wide range of health and disease-related processes, such as cell proliferation and the epithelial-to-mesenchymal transition. The detailed molecular pathway dynamics that coordinate these responses have remained to be determined. To elucidate these, we stimulated MCF-7 breast cancer cells with either FGF2, FGF3, FGF4, FGF10, or FGF19. Following activation of the receptor, we quantified the kinase activity dynamics of 44 kinases using a targeted mass spectrometry assay. Our system-wide kinase activity data, supplemented with (phospho)proteomics data, reveal ligand-dependent distinct pathway dynamics, elucidate the involvement of not earlier reported kinases such as MARK, and revise some of the pathway effects on biological outcomes. In addition, logic-based dynamic modeling of the kinome dynamics further verifies the biological goodness-of-fit of the predicted models and reveals BRAF-driven activation upon FGF2 treatment and ARAF-driven activation upon FGF4 treatment.

SUBMITTER: Veth TS 

PROVIDER: S-EPMC10368922 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elucidating Fibroblast Growth Factor-Induced Kinome Dynamics Using Targeted Mass Spectrometry and Dynamic Modeling.

Veth Tim S TS   Francavilla Chiara C   Heck Albert J R AJR   Altelaar Maarten M  

Molecular & cellular proteomics : MCP 20230615 8


Fibroblast growth factors (FGFs) are paracrine or endocrine signaling proteins that, activated by their ligands, elicit a wide range of health and disease-related processes, such as cell proliferation and the epithelial-to-mesenchymal transition. The detailed molecular pathway dynamics that coordinate these responses have remained to be determined. To elucidate these, we stimulated MCF-7 breast cancer cells with either FGF2, FGF3, FGF4, FGF10, or FGF19. Following activation of the receptor, we q  ...[more]

Similar Datasets

2023-07-02 | PXD038836 | Pride
2023-07-02 | PXD038808 | Pride
2023-07-02 | PXD039005 | panorama
| S-EPMC5980514 | biostudies-literature
| S-EPMC8247967 | biostudies-literature
| S-EPMC9957984 | biostudies-literature
| S-EPMC3190818 | biostudies-literature
| S-EPMC3674507 | biostudies-other
| S-EPMC3771683 | biostudies-literature
2005-09-20 | GSE2744 | GEO